Exelixis Inc

EXEL

Sector
Healthcare

Industry
Biotechnology

Website
exelixis.com




Buy / Sell (dollars)

1 Month

11% 11% Complete (success)
89% 89% Complete (danger)
$524,470.00
avg. $524,470.00
$4.258M
avg. $4.258M

Buy/Sell Ratio

0.123

Transactions

10

Filers

5

3 Month

16.3% 16.3% Complete (success)
83.7% 83.7% Complete (danger)
$3.093M
avg. $1.031M
$15.910M
avg. $5.303M

Buy/Sell Ratio

0.194

Transactions

48

Filers

11

12 Month

15.3% 15.3% Complete (success)
84.7% 84.7% Complete (danger)
$9.471M
avg. $789,278.65
$52.315M
avg. $4.360M

Buy/Sell Ratio

0.181

Transactions

178

Filers

15

24 Month

14.5% 14.5% Complete (success)
85.5% 85.5% Complete (danger)
$14.550M
avg. $606,246.92
$86.084M
avg. $3.587M

Buy/Sell Ratio

0.169

Transactions

270

Filers

17

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers